Impact of Anesthesiology Interventions on Postoperative Outcomes in Adult Patients Undergoing Shoulder Surgery
Impact of Anesthesiology Interventions on Postoperative Outcomes in Adult Patients Undergoing Ambulatory Shoulder Surgery
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Ontario residents
- Aged 18 years and older
- Elective ambulatory shoulder surgery performed in Ontario between April 2009 and December 2016.
Exclusion Criteria:
- Emergency Surgery
- If a patient undergoes multiple elective shoulder surgeries within the time period, only the first surgery will be included for any participant in the study period.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Isolated General Anesthesia
Ontario residents, aged 18 years and older, who have undergone elective ambulatory shoulder surgery in Ontario and have not had a nerve block identified using physician billing codes.
|
No nerve block identified through physician billing codes
Other Names:
|
|
Peripheral Nerve Block
Ontario residents, aged 18 years and older, who have undergone elective ambulatory shoulder surgery in Ontario and have a nerve block identified using physician billing codes.
|
Nerve block identified through physician billing codes
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative Death, Admission, Readmission or Emergency Department Visits
Time Frame: Date of surgery to 7 days (ED visits) and 30 days (readmissions) after surgery or death date, whichever came first
|
Composite outcome of: 1) unplanned admissions on the day of surgery , 2) post-discharge emergency department visits within 7 days of surgery, 3) readmission within 30 days of surgery, and 4) death from any cause
|
Date of surgery to 7 days (ED visits) and 30 days (readmissions) after surgery or death date, whichever came first
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Health System Costs
Time Frame: Date of surgery to 7 days and 30 days after surgery or death date, whichever came first
|
Costs in Canadian dollars will be calculated using standardized patient-level costing algorithms.
|
Date of surgery to 7 days and 30 days after surgery or death date, whichever came first
|
|
Neurology Consultations or Diagnostics
Time Frame: Date of surgery to 90 days after surgery or death date, whichever came first
|
Occurrence of neurology consult and/or nerve conduction study
|
Date of surgery to 90 days after surgery or death date, whichever came first
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Daniel McIsaac, MD, MPH, Department of Anesthesiology and Pain Medicine, University of Ottawa, Ontario, Canada
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- GMH2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.